These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3354819)

  • 1. Hypothermia and the action of neuromuscular blocking agents.
    Mazala M; Horrow JC; Storella RJ
    Anaesthesia; 1988 Feb; 43(2):162. PubMed ID: 3354819
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothermic cardiopulmonary bypass and neuromuscular blockade by pancuronium and vecuronium.
    Buzello W; Schluermann D; Schindler M; Spillner G
    Anesthesiology; 1985 Feb; 62(2):201-4. PubMed ID: 2857541
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of atracurium in cardiac surgery involving cardiopulmonary bypass with induced hypothermia.
    Flynn PJ; Hughes R; Walton B
    Br J Anaesth; 1984 Sep; 56(9):967-72. PubMed ID: 6547844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metocurine kinetics in patients undergoing operations requiring cardiopulmonary bypass.
    Avram MJ; Shanks CA; Henthorn TK; Ronai AK; Kinzer J; Wilkinson CJ
    Clin Pharmacol Ther; 1987 Nov; 42(5):576-81. PubMed ID: 3315392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vecuronium and atracurium infusions during hypothermic cardiopulmonary bypass.
    Denny NM; Kneeshaw JD
    Anaesthesia; 1986 Sep; 41(9):919-22. PubMed ID: 2877590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothermia and neuromuscular blockade.
    Feldman SA
    Anesthesiology; 1979 Oct; 51(4):369-71. PubMed ID: 225969
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuromuscular blockade resistance during therapeutic hypothermia.
    Mueller SW; Winn R; Macht M; Fish DN; Kiser TH; MacLaren R
    Ann Pharmacother; 2011 Mar; 45(3):e15. PubMed ID: 21386017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of atracurium infusions for general surgical procedures including cardiac surgery with induced hypothermia.
    Flynn PJ; Hughes R; Walton B; Jothilingam S
    Br J Anaesth; 1983; 55 Suppl 1():135S-138S. PubMed ID: 6688009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of neuromuscular block in morbidly obese patients following an infusion of rocuronium.
    Spoelders K; van Duffel L; Vandermeersch E; Adriaenssens G; Van de Velde M
    Acta Anaesthesiol Belg; 2001; 52(3):293-5. PubMed ID: 11732386
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular blocking drugs.
    Bevan DR
    Can Anaesth Soc J; 1983 May; 30(3 Pt 2):S56-61. PubMed ID: 6400756
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuromuscular blocking drugs and renal failure.
    Pollard BJ
    Br J Anaesth; 1992 Jun; 68(6):545-7. PubMed ID: 1535206
    [No Abstract]   [Full Text] [Related]  

  • 13. Potency versus onset of neuromuscular blocking agents.
    Gyermek L
    Anesthesiology; 1993 Apr; 78(4):795-7. PubMed ID: 8466083
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of hypothermia on the response to neuromuscular blocking drugs.
    Heier T; Caldwell JE
    Anesthesiology; 2006 May; 104(5):1070-80. PubMed ID: 16645461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular block.
    Feldman S
    Anaesth Intensive Care; 1997 Jun; 25(3):313-4. PubMed ID: 9209625
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative stellate-ganglion blockade to prevent hypertension following coronary-artery operations.
    Estafanous FG; Fouad FM; Tarazi RC
    Anesthesiology; 1980 May; 52(5):454. PubMed ID: 7377590
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect sites of neuromuscular blocking agents and the monitoring of clinical muscle relaxation.
    Meistelman C
    Adv Exp Med Biol; 2003; 523():227-38. PubMed ID: 15088854
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of neuromuscular blocking agents in the intensive care unit.
    Hanson CW
    Crit Care Clin; 1994 Oct; 10(4):779-97. PubMed ID: 8000926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular blockade in the elderly.
    Stankiewicz-Rudnicki M
    Anaesthesiol Intensive Ther; 2016; 48(4):257-260. PubMed ID: 27797097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent clinical advance of rocuronium pharmacokinetics and a new neuromuscular reversal agent, sugammadex].
    Iwasaki H
    Hokkaido Igaku Zasshi; 2012 Aug; 87(4-5):133-5. PubMed ID: 23236656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.